Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Narfurine Hydrochloride in Healthy Chinese Adults
NCT04420234Phase 1Unknown
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nalfurafine in uremic pruritus, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Area Under the Curve, Maximum Plasma Concentration and 11 more. Status: unknown.
02
Drugs
nalfurafine
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT04420234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420234.